Member Info for Chrishar

And what historical metric are you basing this on peoplepower1?

See 15:36 ShareSting's post.

I know similar questions get asked all the time but why doesn't the share price zoom up after these enormous buys? I'd have assumed if it was held down for buys like we've just seen, once they go through it should go through the gears?

Yeah you make a good point Mr Big - I shall sell my £1.3m in Aviva to buy more here.

There's no way of knowing so just wait patiently for the reversal to take place, whether it's today or next week. You'll see some big gains... I promise!

I love it when a share like this rises 10% - there is absolutely no need to even think about banking profits. It's now £1.24 with brokers averaging a £3 target. We could rise 10% each day for the next week and they'd still be so much more to come...

Rich it's a bit rich of you saying that as before results you had zero time for anything negative or any worries being expressed. You shut down anyone who highlighted how risky the investment was and then became Mr balanced the day you took your profits.

Longer term it makes no goddamn difference to NEX what happens to the Dow.

Let's not forget we have an ongoing relationship with the government and DHSC. It was stated that we would provide 288k tests a week for a six month period taking us to October, with the option to extend. Now ask yourself, of all the companies supplying the government which is the one that has delivered? Whilst scandals surround the others ncyt/primer design has exemplified professionalism...

Ramping up testing for the winter it would make no sense to switch suppliers and eschew novacyt don't you think? On that basis I think a new larger contract is nailed on.

Could someone explain to me how these big trades work please? Does the trade only go through once an MM receives £750ks worth of sells? Would an individual get a quote on a trading platform like HL or are they done off book?

No I'm not wrong, that study was done largely on patients that required mechanical ventilation. Sng001 is being trialled on those ranging from asymptomatic/mild (home trials) all the way up to those needing oxygen treatment in hospital.
Funnily enough doctors are not going to be forcing synairgen's nebuliser down the throat of ventilated patients...

For the hundredth millionth time, no. SNG001 is not for those critically ill.

This share price action is extremely unusual. Every time I have seen a share like this in the past there has been some reason that it was so low, usually a very large debt pile. Not in this case. I simply can't work out what's not to like when every broker has a BUY rating with a minimum of 285p, every independent analyst I've read has a buy rating and the oversubscribed placing was at 100% of where we are now... I've even seen recent news of NEX taking over new bus and coach routes.

The only thing I can think of for the continued decline is the uncertainty over what's going to happen with schools/school bus journeys as well as still waiting to appoint a new CEO.

Please stop repeating that line about a lack of vaccine for Sars 'Covic' 1, Woodstock. I've explained numerous times why there isn't one to you, it's not a useful comparison to today's virus. Repeat after me: SARS no longer exists. SARS no longer exists. SARS no longer exists.

Scientists do not create vaccines for obsolete viruses.

Yeah I do agree with you there Deas. It's difficult to ascertain whether the recent signposting we've been getting is a nod to a new agreed contract or an actual sales pitch to the government...

It is so obvious that a deal is about to be agreed, either that or us investors are being heavily misled, for whatever reason?!

It's not enough for the government to promise it however, we need confirmation. Hopefully not long now, GLA!

This is now my second biggest holding having just bought another £6k at 113.3. Just look at the five years before covid - this was one of the most solid growth stocks in the ftse250. The uncertainty around school returns is imo driving the downward pressure on the shares but that will eventually subside and this will turn. £3 in 12 months, £4.50 in 24 months.

I used to think the same thing but don't forget most directors will already have hundreds of thousands of shares in a company, maybe millions... buying hundreds of thousands more will overly expose themselves and so they probably save the hassle and buy other stock instead (where no documentation/rns is necessary).

It still amazes me that we haven't had the COPD results seeing as the unplanned interim analysis was announced on the 26th May. There were many on this forum with experience of trial readouts/investing in biotechs that were expecting the results around the 20th July... and yet I can't imagine those results being anything but positive.

I don't agree. I think a couple of large contracts spanning 18 months (this winter and next) would make all the difference and shift us from what right now is probably a P/E of ~1.2 to something much higher. It doesn't need to be a £300m contract but anything around £100m (and for France) would be meaningful.